KA
GRTS

Klingman & Associates’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Klingman & Associates’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34,786
Closed -$21.5K – 274
2024
Q2 		$21.5K Hold
34,786
– – ﹤0.01% 249
2024
Q1 		$89.4K Buy
+34,786
New +$85K 0.01% 237

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Klingman & Associates's GRTS Position: Q3 2024 in Review

Klingman & Associates sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 34,786 shares — an estimated $21.5K sold.

Klingman & Associates first reported a position in GRTS in Q1 2024 and held it in 2 quarters. The position peaked at $89.4K in Q1 2024. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Klingman & Associates reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Klingman & Associates sold 34,786 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $21.5K.
  • Klingman & Associates first reported a position in Gritstone bio, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Klingman & Associates's Gritstone bio, Inc. Common Stock position peaked at $89.4K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Klingman & Associates's 13F filing for Q3 2024, filed 1 Nov 2024.